Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
Nuvectis Pharma, Inc. (NVCT) had Return on Assets of -31.37% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-7.02M |
|
-- |
|
-- |
|
$7.20M |
|
$-7.20M |
|
$0.18M |
|
$-7.02M |
|
$-7.02M |
|
$-7.02M |
|
$-7.02M |
|
$-7.02M |
|
$-7.02M |
|
$-7.20M |
|
$-7.20M |
|
23.48M |
|
23.48M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$22.38M |
|
-- |
|
-- |
|
$22.38M |
|
$13.29M |
|
-- |
|
-- |
|
$13.29M |
|
$9.08M |
|
$9.08M |
|
$9.08M |
|
26.70M |
|
| Cash Flow Statement Financials | |
$-11.04M |
|
-- |
|
$1.57M |
|
$31.63M |
|
$22.16M |
|
$-9.47M |
|
$3.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-77.30% |
|
-77.30% |
|
|
Return on Assets |
-31.37% |
-77.30% |
|
$0.34 |
|
$-0.47 |
|
$-0.47 |
|